Melissa Adams: Daily

This strategic acquisition combines AI-driven tech with deep clinical expertise to help hospitals fight rising claim denials and severe margin pressure.

The wildly popular DTC supplement AG1 lands in 640+ Vitamin Shoppe stores. This landmark deal signals a major shift for wellness retail and consumer trust.

Dreame, known for vacuums, stuns CES with a thumb-sized 8K AI camera and a wearable ecosystem, posing a serious challenge to GoPro and DJI.

A federal court blocked Edwards Lifesciences' key acquisition, citing monopoly fears, yet the company's financial outlook surprisingly improves.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

Automated Industrial Robotics Inc. acquires Ireland's KAON Automation, a strategic move to dominate the high-stakes medical and life sciences market.

Major insurers now cover advanced AI plaque analysis, paving the way for personalized heart attack prevention and a new standard of cardiovascular care.

Preliminary talks between mining giants Rio Tinto and Glencore could forge a $200B+ behemoth, igniting market volatility and intense regulatory scrutiny.

A new report finds 90% of nurses miss key updates due to flawed communication, leading to patient care errors and fueling the nursing staff crisis.

Zoom launches a new grant program celebrating solo entrepreneurs using AI, signaling a strategic bet on the rapidly growing 'business of one' economy.

A new partnership brings early wage access to millions via PayPal, aiming to serve the unbanked and signaling a major shift in employee financial wellness.

The biotech firm launches an early access program for its novel platform, starting with a tau assay that could revolutionize Alzheimer's research.

A looming 10-million-ton copper deficit threatens to derail the AI revolution and the green energy transition, sparking a new era of geopolitical competition.

Challenger brand Kodiak partners with analytics giant NIQ, signaling a new data-driven era for competition in the crowded CPG breakfast and snacking aisles.

Azafaros presents its promising drug, nizubaglustat, for untreatable rare neurological disorders, backed by major funding and late-stage clinical trials.

The partnership, unveiled at CES 2026, will leverage Qualcomm's chips to accelerate Software-Defined Vehicle development for high-growth emerging markets.

NEI is streamlining its lineup by merging two global equity funds. Here’s what investors need to know about the performance, fees, and strategy shift.

New research confirms a soil inoculant improves nutrient retention and crop health, offering farmers a tool for both profit and sustainability.

The modular builder pivots dramatically, rebranding as Olenox Industries to chase growth in energy, tech, and infrastructure through a bold new strategy.

Global design firm Populous is evolving, adding real estate strategy to its services to create entire entertainment ecosystems, not just stadiums.